SynthesisEndocrine2014
Associations between rs965513/rs944289 and papillary thyroid carcinoma risk: a meta-analysis.
Synthesis in Endocrine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.
- rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer.Oncotarget · 2016Pooled it
- Article
- Evaluation of common genetic risk factors for differentiated thyroid cancer in the Thai population.Biomedical reports · 2025Article
- Association between long noncoding RNA rs944289 and rs7990916 polymorphisms and the risk of colorectal cancer in a Chinese population.Scientific reports · 2022Article
- Association analysis between the interaction of RAS family genes mutations and papillary thyroid carcinoma in the Han Chinese population.International journal of medical sciences · 2021Observational
- Genetic Variants Associated with Thyroid Cancer Risk: Comprehensive Research Synopsis, Meta-Analysis, and Cumulative Epidemiological Evidence.Journal of oncology · 2021Review
- A new panel of SNPs to assess thyroid carcinoma risk: a pilot study in a Brazilian admixture population.BMC medical genetics · 2017Article
- MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus.Proceedings of the National Academy of Sciences of the United States of America · 2017Article
- Clinical features of Hispanic thyroid cancer cases and the role of known genetic variants on disease risk.Medicine · 2016Article
- INTEGRATING CLINICAL LABORATORY MEASURES AND ICD-9 CODE DIAGNOSES IN PHENOME-WIDE ASSOCIATION STUDIES.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2016Article
- Genetic predisposition for nonmedullary thyroid cancer.Hormones & cancer · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-nucleotide polymorphisms of rs965513 (9q22.33) and rs944289 (14q13.3) may be involved in the pathogenesis of papillary thyroid carcinoma (PTC). But, relevant genetic studies reported different results. The aim of this meta-analysis was to derive a more precise assessment of the association of rs965513/rs944289 polymorphism with PTC risk. Relevant studies were identified using PubMed, ISI Web of knowledge, Medline, Embase, Google Scholar Search database, SinoMed (Chinese), CNKI (Chinese), GeNii (Japanese) and ICHUSHI (Japanese) (update to December, 2013). A total of eight case-control studies with 52,363 subjects for rs965513 and 51,120 subjects for rs944289 were included. The results showed significant associations of rs965513/rs944289 with PTC risk existed in overall population (for rs965513, A vs. G: OR 1.71 (1.56-1.86); for rs944289, T vs. C: OR 1.29 (1.23-1.37)). Subgroup analysis by ethnicity showed that there were significant associations in Asians (for rs965513, A vs. G: OR 1.48 (1.27-1.73); for rs944289, T vs. C: OR 1.35 (1.18-1.55)), in Europeans (for rs965513, A vs. G: OR 1.74 (1.61-1.88); for rs944289, T vs. C: OR 1.24 (1.14-1.34)), and in Americans (for rs965513, A vs. G: OR 2.00 (1.76-2.27); for rs944289, T vs. C: OR 1.29 (1.14-1.47)). In conclusion, Rs965513 [A] and rs944289 [T] are risk factors of PTC. Effect estimate for rs965513 polymorphism is higher in Americans than in Asians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.